Quantitative determination of trans-polydatin, a natural strong anti-oxidative compound, in rat plasma and cellular environment of a human colon adenocarcinoma cell line for pharmacokinetic studies
- PMID: 17606417
- DOI: 10.1016/j.jchromb.2007.04.035
Quantitative determination of trans-polydatin, a natural strong anti-oxidative compound, in rat plasma and cellular environment of a human colon adenocarcinoma cell line for pharmacokinetic studies
Abstract
A simple, accurate, precise, specific and reproducible high-performance liquid chromatography (HPLC) method was developed for determination of trans-polydatin, a natural strong anti-oxidative compound, in rat plasma and cell suspension. The assay procedure involved simple liquid-liquid extraction, the supernatant liquid was added an equal volume of water to avoid solvent effect. The detection of the analyte peak was achieved by monitoring the eluate using a UV detector set at 303 nm. The analysis used a Hypersil ODS2 C18 column (5 microm, 4.6 mm x 250 mm) and methanol/distilled water as the mobile phase (flow rate=1 mL/min). A total analytical run was achieved within 6.0 min and calibration curve was linear over a wide concentration range of 0.25-40 microg/mL for plasma sample and 1.0-500 microM for cell suspension, the coefficients of correlation were 0.9997 and 0.9999 or better, respectively. There was 80.7+/-7.86%, 96.8+/-3.20% and 102.7+/-9.72% recovery from 0.5, 10, and 40 microg/mL plasma samples, respectively. Intra- and inter-batch accuracy and precision were acceptable for the both matrices. The RSD of intra- and inter-day assay variations were all less than 10%. Both analyte and IS were stable in the battery of stability studies, freeze-thaw cycles. The described assay method was applied to pharmacokinetic studies in rats and a human colon adenocarcinoma cell line (Caco-2) successfully. The application of the assay to determine the pharmacokinetic is described.
Similar articles
-
Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmacokinetic studies.Biomed Chromatogr. 2007 Mar;21(3):257-65. doi: 10.1002/bmc.747. Biomed Chromatogr. 2007. PMID: 17294509
-
A high-performance liquid chromatographic method for determination of scopolin in rat plasma: application to pharmacokinetic studies.Biomed Chromatogr. 2008 Oct;22(10):1137-42. doi: 10.1002/bmc.1036. Biomed Chromatogr. 2008. PMID: 18506740
-
Determination of rosuvastatin in rat plasma by HPLC: Validation and its application to pharmacokinetic studies.Biomed Chromatogr. 2006 Sep;20(9):881-7. doi: 10.1002/bmc.611. Biomed Chromatogr. 2006. PMID: 16389642
-
Quantitative determination of ragaglitazar in rat plasma by HPLC: validation and application in pharmacokinetic study.Biomed Chromatogr. 2002 Dec;16(8):495-9. doi: 10.1002/bmc.190. Biomed Chromatogr. 2002. PMID: 12474210
-
Simultaneous enantiomer determination of 20 (R)- and 20 (S)-ginsenoside-Rg2 in rat plasma after intravenous administration using HPLC method.J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 1;850(1-2):1-6. doi: 10.1016/j.jchromb.2006.11.008. Epub 2006 Nov 20. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17113840 Review.
Cited by
-
The Neuroprotective Role of Polydatin: Neuropharmacological Mechanisms, Molecular Targets, Therapeutic Potentials, and Clinical Perspective.Molecules. 2021 Oct 2;26(19):5985. doi: 10.3390/molecules26195985. Molecules. 2021. PMID: 34641529 Free PMC article. Review.
-
A Versatile Method to Determine the Cellular Bioavailability of Small-Molecule Inhibitors.J Med Chem. 2017 Jan 12;60(1):157-169. doi: 10.1021/acs.jmedchem.6b00923. Epub 2017 Jan 3. J Med Chem. 2017. PMID: 27935314 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical